{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:34:49Z","timestamp":1785861289514,"version":"3.56.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"DOI":"10.1097\/01.aids.0000238409.90571.02","type":"journal-article","created":{"date-parts":[[2006,7,24]],"date-time":"2006-07-24T04:19:07Z","timestamp":1153714747000},"page":"1627-1635","source":"Crossref","is-referenced-by-count":49,"title":["Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy"],"prefix":"10.1097","volume":"20","author":[{"given":"Murielle","family":"Mary-Krause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Billaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Poizot-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dhiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Roudiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0140-6736(00)02069-9","article-title":"Survival after introduction of HAART in people with known duration of HIV-1 infection.","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"R3-8-20210130","first-page":"451","article-title":"Avascular necrosis of the hip in a man with HIV infection","volume":"66","author":"Goorney","year":"1990","journal-title":"Genitourin Med"},{"key":"R4-8-20210130","first-page":"300","article-title":"Multiple site avascular necrosis in HIV infected patients","volume":"18","author":"Gerster","year":"1991","journal-title":"J Rheumatol"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s150100070049","article-title":"Avascular necrosis of the femoral head: a side effect of highly active antiretroviral therapy (HAART) in HIV patients?","volume":"28","author":"Sighinolfi","year":"2000","journal-title":"Infection"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00002030-199906180-00025","article-title":"Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors","volume":"13","author":"Meyer","year":"1999","journal-title":"AIDS"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/317503","article-title":"Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus","volume":"31","author":"Monier","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitor","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection","volume":"13","author":"Safrin","year":"1999","journal-title":"AIDS"},{"key":"R11-8-20210130","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-8-20210130","first-page":"559","article-title":"The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B","volume":"76","author":"Feingold","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl A","key":"R15-8-20210130","first-page":"S69","article-title":"The incubation period of AIDS","volume":"11","author":"Munoz","year":"1997","journal-title":"AIDS"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0140-6736(93)93040-8","article-title":"Expanded European AIDS definition","volume":"341","author":"Ancelle-Park","year":"1993","journal-title":"Lancet"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-137-1-200207020-00008","article-title":"High prevalence of osteonecrosis on the femoral head in HIV-infected adults","volume":"137","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"R19-8-20210130","first-page":"247","article-title":"Daignostic imaging of avascular necrosis of the hip. American College of Radiology appropriateness criteria","volume":"215","author":"DeSmet","year":"2000","journal-title":"Radiology"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1148\/rg.232025103","article-title":"Radionuclide bone imaging: an illustrative review","volume":"23","author":"Love","year":"2003","journal-title":"Radiographics"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Assouline-Davan","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00126334-200009010-00003","article-title":"Osteonecrosis in HIV: a case-control study","volume":"25","author":"Scribner","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-8-20210130","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.60.12.1145","article-title":"Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment","volume":"60","author":"Oinumaz","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R24-8-20210130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/322779","article-title":"Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study","volume":"184","author":"Glesby","year":"2001","journal-title":"J Infect Dis"},{"key":"R25-8-20210130","first-page":"22","article-title":"Osteonecrosis and HIV disease","volume":"15","author":"Cheonis","year":"2002","journal-title":"Bull Exp Treat AIDS"},{"key":"R26-8-20210130","first-page":"1","article-title":"Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management","volume":"17","author":"Allison","year":"2003","journal-title":"AIDS"},{"issue":"Suppl 2","key":"R27-8-20210130","first-page":"23S","article-title":"Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus","volume":"118","author":"Grinspoon","year":"2005","journal-title":"Am J Med"},{"key":"R29-8-20210130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/108729101750301933","article-title":"Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review","volume":"15","author":"Calza","year":"2001","journal-title":"AIDS Patient Care STD"},{"key":"R30-8-20210130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0899-7071(99)00151-5","article-title":"Avascular necrosis of bone in human immunodeficiency virus infected patients","volume":"23","author":"Blacksin","year":"2000","journal-title":"Clin Imaging"},{"key":"R31-8-20210130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002030-200301240-00016","article-title":"Is HIV sequestered in bone? Possible","volume":"17","author":"Fessel","year":"2003","journal-title":"AIDS"},{"key":"R32-8-20210130","first-page":"601","article-title":"Osteonecrosis and human immunodeficiency virus infection","volume":"24","author":"Rademaker","year":"1997","journal-title":"J Rheumatol"},{"key":"R33-8-20210130","first-page":"10","article-title":"Bone disorders, hypertension, and mitochondrial toxicity in HIV disease","volume":"11","author":"Newman","year":"2003","journal-title":"Top HIV med"},{"key":"R34-8-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/375844","article-title":"Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population","volume":"37","author":"Sav\u00e8s","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R35-8-20210130","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.7326\/0003-4819-137-1-200207020-00008","article-title":"High prevalence of osteonecrosis of the femoral head in HIV-infected adults","volume":"137","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"key":"R36-8-20210130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00002030-200202150-00021","article-title":"Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors","volume":"16","author":"Guti\u00e9rrez","year":"2002","journal-title":"AIDS"},{"key":"R37-8-20210130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/aid.2004.20.909","article-title":"Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV cohort study: a nested case-control study","volume":"20","author":"Hasse","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R38-8-20210130","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/428837","article-title":"Avascular necrosis in HIV-infected patients: a case-control study from the Aquitaine Cohort, 1997\u20132000, France","volume":"40","author":"Lawson-Ayayi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R39-8-20210130","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1097\/00002030-200009080-00026","article-title":"Osteonecrosis of the hip, lipodystrophy and antiretroviral treatment","volume":"14","author":"Roudi\u00e8re","year":"2000","journal-title":"AIDS"},{"key":"R40-8-20210130","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1097\/00002030-200009290-00028","article-title":"Bone mineral loss in HIV-positive patients receiving antiretroviral therapy","volume":"14","author":"Weiel","year":"2000","journal-title":"AIDS"},{"key":"R41-8-20210130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.qai.0000131585.77530.64","article-title":"Effect of nucleoside reverse transcriptase inhibitors on mitochondrial DNA synthesis in rats and humans","volume":"37","author":"Collins","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-8-20210130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/135965350300800614","article-title":"Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level","volume":"8","author":"Nolan","year":"2003","journal-title":"Antivir Ther"},{"key":"R43-8-20210130","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1086\/324353","article-title":"Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study","volume":"33","author":"Boubaker","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200608010-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:41:42Z","timestamp":1785858102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200608010-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000238409.90571.02","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}